Charts and Commentary For Feb. 27, 2014. $SGYP $SYN $XNPT $XOMA $HALO $RIGL quick review. Commentary on Dark Pool heavy selling and what it could mean + commentary on protecting profits over worrying about “missing out” on a trade/stock move.…
Month: February 2014
Video Market Commentary, Feb. 25, 2014
Market wrap up and commentary, reiteration on how to trade properly. Commentary on positions we have been trading plus >> twitter drama report and once again, HOW TO TRADE properly. Always have a goal in every trade, including how much…
Xenoport Gaining Momentum, Could It Be The Next Small Cap Biotech Flyer?
Xenoport (XNPT) focuses on developing and commercializing a portfolio of internally discovered product candidates for the treatment of neurological disorders. XenoPort is working on advancing XP23829 into phase III studies for treatment of relapsing forms of multiple sclerosis. The company…
Video Chart Review For Feb. 24, 2014
Chart Review For Feb. 24, 2014.. $SGYP $RIGL $XNPT $XOMA $SPY $DJI $QQQ reviewed in detail. Market and chart predictions covered, Enjoy! Scott
Market Commentary Feb. 24, 2014
Market Commentary Feb. 24, 2014. Some commentary on $CHTP, $RIGL, and $XNPT. No chart reviews on this video. Additionally, some macro news reviewed plus some commentary on how to TAKE LOSSES correctly in a trade, Enjoy! Scott
Trade Alert: Bought $XNPT for Strong Chart + Early March Presentation Target Opinion – $7
Trade Alert: Bought $XNPT for Strong Chart + Early March Presentation. Target $7. We bought $XNPT because of a nice channel trade and a MACD cross. The chart is hitting the bottom of its recent trend line that it has…
We Bought $RIGL, Target Opinion $4 – $4.25 Reason = Acquisition Rumor
We Bought Rigel Pharmaceuticals ($RIGL), Target Opinion $4 – $4.25 Reason = Acquisition Rumor + 2H Data Phase II data due in the second half of 2014 of R348 for Chronic dry eye disease, Sources we have spoken with indicate this…
Video: Chart Commentary Reading Trader Sentiment 2/22/14
Chart Commentary And How to Read Trader Sentiment 2/22/14. $IDRA $PRAN $SGYP $XOMA $MNKD + commentary on what Kyle and I look for in terms of a developmental small cap biotech break out about to occur in the stock channel.…
Trade Alert: We Bought $IDRA Target Opinion $6-$6.25
We bought $IDRA with a price target opinion of $6-$6.25. Idera expects to report top-line data from the first three dosing groups of the Phase II trial for Psoriasis in the first quarter of 2014 and to report top-line data…
Video: Charts and Commentary For Feb 20, 2014
Charts and Commentary For Feb 20, 2014. $SGYP $NEON $HALO $ACRX $MNKD $SYN $PRAN reviewed + Market commentary and outlook. There is a slight humming sound in video for some reason that happens every now and then, but nothing bad.…